Inositol Polyphosphate Multikinase Is a Metformin Target That Regulates Cell Migration
Open accessAbstract
Metformin has been shown to alter cell adhesion protein expression, which is thought to play a role in its observed antitumor properties. We found that metformin treatment down‐regulated integrin β1 concomitant with the loss of inositol polyphosphate multikinase (IPMK) in murine myocytes, adipocytes, and hepatocytes. To determine if IPMK was upstream of integrin β1 expression, we examined IPMK ‐/‐ mouse embryonic fibroblast cells and found that integrins β1and β3 gene expression was reduced by half, relative to wild‐type cells, whereas focal adhesion kinase (FAK) activity and Rho/Rac/Cdc42 protein levels were increased, resulting in migration defects. Using nanonet force microscopy, we determined that cell:extracellular matrix adhesion and cell contractility forces were decreased, confirming the functional relevance of integrin and Rho protein dysregulation. Pharmacological studies showed that inhibition of both FAK1 and proline‐rich tyrosine kinase 2 partially restored integrin β1 expression, suggesting negative regulation of integrin β1 by FAK. Together our data indicate that IPMK participates in the regulation of cell migration and provides a potential link between metformin and wound healing impairment.—Tu‐Sekine, B., Padhi, A., Jin, S., Kalyan, S., Singh, K., Apperson, M., Kapania, R., Hur, S. C., Nain, A., Kim, S. F. Inositol polyphosphate multikinase is a metformin target that regulates cell migration. FASEB J. 33, 14137‐14146 (2019). www.fasebj.org
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IPMK's lipid kinase activity promotes cell migration in immortalized mouse embryonic fibroblast cells.
“Studies by Sekine et al. [54] and Reilly et al. [34] have highlighted the significant role of IPMK’s lipid kinase activity in promoting cell migration in immortalized mouse embryonic fibroblast cells (MEFs).”
From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [54]
The Results (page unavailable) report that IPMK-deficient MEFs migrated more slowly than wild-type cells and that active IPMK, but not kinase-dead IPMK, accelerated wound closure. These experiments support a role for IPMK’s catalytic activity in MEF migration, but they do not isolate its lipid kinase activity from its other catalytic activity or establish that the MEFs were immortalized. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIPMK plays a crucial role in migration.
“It plays a crucial role in cell proliferation [34], metabolism [58], autophagy [14,64], and migration [34,53,54].”
From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [54]
Deletion of IPMK or inhibition of its kinase activity results in impaired cell migration.
“Deletion of IPMK or inhibition of its kinase activity resulted in impaired cell migration, indicating its essential function in this process.”
From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [54]
Attempts to rescue cell migration in IPMK-deleted MEFs by overexpressing β1 integrin were unsuccessful.
“However, attempts to rescue cell migration in IPMK-deleted MEFs by overexpressing β1 integrin were unsuccessful [54], suggesting that integrin-independent pathways likely play a role in IPMK-mediated cell migration.”
From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [54]
In Dictyostelium, cells with cPI3K genetically eliminated still migrate but are substantially retarded.
“However, studies conducted in the model organism Dictyostelium, where cPI3K was genetically eliminated, revealed that cells still migrate but are substantially retarded [53,54].”
From From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease (2025) · cites this paper as [54]
The Results (page unavailable) report that mouse embryonic fibroblasts lacking IPMK still migrated, but more slowly than wild-type cells. Searches for Dictyostelium and genetically eliminated cPI3K found no passage addressing migration in those cells; the reported result concerns a different organism and gene. (LLM, conf=0.77)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Distinctive Image Features from Scale-Invariant Keypoints
Lowe, D. G. (2004) · International Journal of Computer Vision · doi:10.1023/b:visi.0000029664.99615.94 · Cited by 55,589 · see citing works
Flagged first, then by citations
Research works printed but not linked: 42
- [1]Bang S., Kim S., Dailey M. J., Chen Y., Moran T. H., Snyder S. H., Kim S. F. (2012) AMP-activated protein kinase is physiologically regulated by inositol polyphosphate multikinase. Proc. Natl. Acad. Sci. USA 109, 616–620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2]Bang S., Chen Y., Ahima R. S., Kim S. F. (2014) Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. Mol. Endocrinol. 28, 1186–1193 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3]Kim S., Kim S. F., Maag D., Maxwell M. J., Resnick A. C., Juluri K. R., Chakraborty A., Koldobskiy M. A., Cha S. H., Barrow R., Snowman A. M., Snyder S. H. (2011) Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metab. 13, 215–221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4]Arnold S. E., Lucki I., Brookshire B. R., Carlson G. C., Browne C. A., Kazi H., Bang S., Choi B. R., Chen Y., McMullen M. F., Kim S. F. (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol. Dis. 67, 79–87 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5]Schexnayder C., Broussard K., Onuaguluchi D., Poché A., Ismail M., McAtee L.F., Llopis S., Keizerweerd A., McFerrin H., Williams C. (2018) Metformin inhibits migration and invasion by suppressing ROS production and COX2 expression in MDA-MB-231 breast cancer cells. Int. J. Mol. Sci. 19, 1–13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6]Yi Y., Chen D., Ao J., Sun S., Wu M., Li X., Bergholz J., Zhang Y., Xiao Z. X. (2017) Metformin promotes AMP-activated protein kinaseindependent suppression of δnp63α protein expression and inhibits cancer cell viability. J. Biol. Chem. 292, 5253–5261 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7]Qiang P., Shao Y., Sun Y. P., Zhang J., Chen L. J. (2019) Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway. Eur. Rev. Med. Pharmacol. Sci. 23, 1778–1785 [DOI] [PubMed] [Google Scholar]
- [8]Jang S. Y., Kim A., Kim J. K., Kim C., Cho Y. H., Kim J. H., Kim C. H., Lee J. Y. (2014) Metformin inhibits tumor cell migration via down-regulation of MMP9 in tamoxifen-resistant breast cancer cells. Anticancer Res. 34, 4127–4134 [PubMed] [Google Scholar]
- [9]Yu T., Wang C., Yang J., Guo Y., Wu Y., Li X. (2017) Metformin inhibits SUV39H1-mediated migration of prostate cancer cells. Oncogenesis 6, e324 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10]Ochoa-Gonzalez F., Cervantes-Villagrana A. R., Fernandez-Ruiz J. C., Nava-Ramirez H. S., Hernandez-Correa A. C., Enciso-Moreno J. A., Castañeda-Delgado J. E. (2016) Metformin induces cell cycle arrest, reduced proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS One 11, e0150900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11]Fesseha B. K., Abularrage C. J., Hines K. F., Sherman R., Frost P., Langan S., Canner J., Likes K. C., Hosseini S. M., Jack G., Hicks C. W., Yalamanchi S., Mathioudakis N. (2018) Association of hemoglobin A1c and wound healing in diabetic foot ulcers. Diabetes Care 41, 1478–1485 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12]Reig G., Pulgar E., Concha M. L. (2014) Cell migration: from tissue culture to embryos. Development 141, 1999–2013 [DOI] [PubMed] [Google Scholar]
- [13]Lamouille S., Xu J., Derynck R. (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14]Jadav R. S., Kumar D., Buwa N., Ganguli S., Thampatty S. R., Balasubramanian N., Bhandari R. (2016) Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice. Cell. Signal. 28, 1124–1136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15]Insall R. H., Weiner O. D. (2001) PIP3, PIP2, and cell movement--similar messages, different meanings? Dev. Cell 1, 743–747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16]Welf E. S., Ahmed S., Johnson H. E., Melvin A. T., Haugh J. M. (2012) Migrating fibroblasts reorient directionality by a metastable, PI3K-dependent mechanism. J. Cell Biol. 197, 105–114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17]Burridge K., Fath K. (1989) Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. BioEssays 10, 104–108 [DOI] [PubMed] [Google Scholar]
- [18]Giancotti F. G., Ruoslahti E. (1999) Integrin signaling. Science 285, 1028–1032 [DOI] [PubMed] [Google Scholar]
- [19]Kim C., Ye F., Ginsberg M. H. (2011) Regulation of integrin activation. Annu. Rev. Cell Dev. Biol. 27, 321–345 [DOI] [PubMed] [Google Scholar]
- [20]Hynes R. O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 [DOI] [PubMed] [Google Scholar]
- [21]Barczyk M., Carracedo S., Gullberg D. (2010) Integrins. Cell Tissue Res. 339, 269–280 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22]Koivisto L., Heino J., Häkkinen L., Larjava H. (2014) Integrins in wound healing. Adv. Wound Care (New Rochelle) 3, 762–783 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23]Resnick A. C., Snowman A. M., Kang B. N., Hurt K. J., Snyder S. H., Saiardi A. (2005) Inositol polyphosphate multikinase is a nuclear PI3-kinase with transcriptional regulatory activity. Proc. Natl. Acad. Sci. USA 102, 12783–12788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24]Maag D., Maxwell M. J., Hardesty D. A., Boucher K. L., Choudhari N., Hanno A. G., Ma J. F., Snowman A. S., Pietropaoli J. W., Xu R., Storm P. B., Saiardi A., Snyder S. H., Resnick A. C. (2011) Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proc. Natl. Acad. Sci. USA 108, 1391–1396 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25]Xu R., Paul B. D., Smith D. R., Tyagi R., Rao F., Khan A. B., Blech D. J., Vandiver M. S., Harraz M. M., Guha P., Ahmed I., Sen N., Gallagher M., Snyder S. H. (2013) Inositol polyphosphate multikinase is a transcriptional coactivator required for immediate early gene induction. Proc. Natl. Acad. Sci. USA 110, 16181–16186 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26]Malabanan M. M., Blind R. D. (2016) Inositol polyphosphate multikinase (IPMK) in transcriptional regulation and nuclear inositide metabolism. Biochem. Soc. Trans. 44, 279–285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27]Parsons M., Messent A. J., Humphries J. D., Deakin N. O., Humphries M. J. (2008) Quantification of integrin receptor agonism by fluorescence lifetime imaging. J. Cell Sci. 121, 265–271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28]Han S. J., Choi S. E., Yi S. A., Jung J. G., Jung I. R., Shin M., Kang S., Oh H., Kim H. J., Kim D. J., Kwon J. E., Choi C. S., Lee K. W., Kang Y. (2016) Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. Sci. Rep. 5, 37468 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29]Nain A. S., Sitti M., Jacobson A., Kowalewski T., Amon C. (2009) Dry spinning based spinneret based tunable engineered parameters (STEP) technique for controlled and aligned deposition of polymeric nanofibers. Macromol. Rapid Commun. 30, 1406–1412 [DOI] [PubMed] [Google Scholar]
- [30]Nain A. S., Wang J. (2013) Polymeric nanofibers: isodiametric design space and methodology for depositing aligned nanofiber arrays in single and multiple layers. Polym. J. 45, 695–700 [Google Scholar]
- [31]Chalfoun J., Majurski M., Blattner T., Bhadriraju K., Keyrouz W., Bajcsy P., Brady M. (2017) MIST: accurate and scalable microscopy image stitching tool with stage modeling and error minimization. Sci. Rep. 7, 4988 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33]Piccinini F., Kiss A., Horvath P. (2016) CellTracker (not only) for dummies. Bioinformatics 32, 955–957 [DOI] [PubMed] [Google Scholar]
- [34]Sheets K., Wang J., Zhao W., Kapania R., Nain A. S. (2016) Nanonet force microscopy for measuring cell forces. Biophys. J. 111, 197–207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [35]Hall A., Chan P., Sheets K., Apperson M., Delaughter C., Gleason T. G., Phillippi J. A., Nain A. (2017) Nanonet force microscopy for measuring forces in single smooth muscle cells of the human aorta. Mol. Biol. Cell 28, 1894–1900 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36]Hou S., Isaji T., Hang Q., Im S., Fukuda T., Gu J. (2016) Distinct effects of β1 integrin on cell proliferation and cellular signaling in MDA-MB-231 breast cancer cells. Sci. Rep. 6, 18430 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37]Koons B., Sharma P., Ye Z., Mukherjee A., Lee M. H., Wirtz D., Behkam B., Nain A. S. (2017) Cancer protrusions on a tightrope: nanofiber curvature contrast quantitates single protrusion dynamics. ACS Nano 11, 12037–12048 [DOI] [PubMed] [Google Scholar]
- [38]Slack-Davis J. K., Martin K. H., Tilghman R. W., Iwanicki M., Ung E. J., Autry C., Luzzio M. J., Cooper B., Kath J. C., Roberts W. G., Parsons J. T. (2007) Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 282, 14845–14852 [DOI] [PubMed] [Google Scholar]
- [39]Calalb M. B., Polte T. R., Hanks S. K. (1995) Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954–963 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [40]Fu C., Xu J., Cheng W., Rojas T., Chin A. C., Snowman A. M., Harraz M. M., Snyder S. H. (2017) Neuronal migration is mediated by inositol hexakisphosphate kinase 1 via α-actinin and focal adhesion kinase. Proc. Natl. Acad. Sci. USA 114, 2036–2041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41]Scherer P. C., Ding Y., Liu Z., Xu J., Mao H., Barrow J. C., Wei N., Zheng N., Snyder S. H., Rao F. (2016) Inositol hexakisphosphate (IP6) generated by IP5K mediates cullin-COP9 signalosome interactions and CRL function. Proc. Natl. Acad. Sci. USA 113, 3503–3508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42]Li X., Dy R. C., Cance W. G., Graves L. M., Earp H. S. (1999) Interactions between two cytoskeleton-associated tyrosine kinases: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase. J. Biol. Chem. 274, 8917–8924 [DOI] [PubMed] [Google Scholar]
- [43]Murphy J. M., Park H., Lim S.-T. (2016) {FAK} and Pyk2 in disease. Front. Biol. (Beijing) 11, 1–9 [Google Scholar]
Cited by
Sorted by citations
From Obscurity to Prominence: IPMK’s Expanding Role in Cellular Signaling, Physiology, and Disease
Mishra, S. H., Chatterjee, S., Viera-Preval, L., & Guha, P. (2025) · Biomolecules · doi:10.3390/biom15091266 · Cited by 1 · see citing works
“Specifically, the loss of IPMK activity may lead to decreased expression of β 1 and β 3 integrins [54], which are critical cell surface receptors that facilitate cell migration through the activation of focal adhesion kinase (FAK) and Rho signaling pathways.”
Influential
- Authors
- Tu‐Sekine, B., Padhi, A., Jin, S., Kalyan, S., Singh, K., Apperson, M., Kapania, R., Hur, S. C., Nain, A., & Kim, S. F.
- Affiliations
- Johns Hopkins University (US)
- Virginia Tech (US)
- Corresponding author
- Kim, Sangwon F.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2019-10-30
- Volume
- 33
- Issue
- 12
- Pages
- 14137-14146
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC6894044
- OpenAlex
- W2981346204
- Cited by
- 20
- References
- 1
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 2 · 2019: 2
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-08-28)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA568921)
- American Heart Association (17SFRN33610014)
- National Science Foundation (1437101, 1462916)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- inositol polyphosphate multikinase, metformin, cell migration, beta1 integrin, CD61, focal adhesion kinase, cell adhesion, cell contractility, wound healing, PRK2, antitumor drug targets
- MeSH terms
- Animals, Cell Movement, Fibroblasts, Hypoglycemic Agents, Metformin, Down-Regulation, Gene Expression Regulation, Enzymologic, Phosphotransferases (Alcohol Group Acceptor), Mice, Knockout, Integrin beta1, Mice, Focal Adhesion Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review